Defying broader market volatility and economic uncertainty, CVS Health (NYSE: CVS) has delivered a stellar performance in ...

Globe Investor value reports provide a daily price target for more than 9,000 stocks on the TSX, Nasdaq, and NYSE. Used by ...

CVS Health Corp.’s drug benefits unit is trying to entice health insurance plans to cover Wegovy, Novo Nordisk A/S’s pricey weight-loss shot, for more patients by allowing them to charge copays as ...

In the first quarter of 2025, CVS Health’s CVS Health Care Benefits segment grew 8% year over year, mainly due to strength in Medicare. Elevated utilization trends in inpatient, outpatient and medical ...

In the past week, CVS Health's pharmacy benefit manager Caremark announced a new $200 copay program for Novo Nordisk's weight ...

Rising prescription costs? CVS Caremark’s Joshua Fredell explains how to cut expenses by knowing your drug benefits, choosing ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain ...

CVS Health has received a modest upward revision to its Fair Value Estimate, which has increased from $82.07 to $83.79 per ...

The company said Wednesday that it is operating former Rite Aid and Bartell Drugs stores in Idaho, Oregon and Washington. It ...

Plaintiffs are challenging CVS Caremark’s decision to stop covering Zepbound, a weight-loss drug also used to treat sleep apnea.

On Tuesday, CVS Health announced that it completed the acquisition of Rite Aid assets nationwide with the addition of 63 ...